Lee Financial CO Organon & Co. Transaction History

Lee Financial CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	BUY	$10.95 - $17.32 $2,091 - $3,308	191 Added 868.18%	213 $3,000
Q1 2023 May 15, 2023	SELL	$21.42 - $32.08 $642 - $962	-30 Reduced 57.69%	22 $0
Q3 2022 Nov 01, 2022	SELL	$23.4 - $34.25 $655 - $959	-28 Reduced 35.0%	52 $1,000
Q2 2022 Aug 10, 2022	SELL	$31.66 - $38.9 $569 - $700	-18 Reduced 18.37%	80 $3,000
Q1 2022 May 11, 2022	BUY	$30.45 - $39.36 $669 - $865	22 Added 28.95%	98 $3,000
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $687 - $855	24 Added 46.15%	76 $2,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $1,479 - $1,976	52 New	52 $2,000

809

207M

1.19M

910K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.